28 related articles for article (PubMed ID: 38474001)
1. Pigment epithelium-derived factor (PEDF) inhibits breast cancer metastasis by down-regulating fibronectin.
Hong H; Zhou T; Fang S; Jia M; Xu Z; Dai Z; Li C; Li S; Li L; Zhang T; Qi W; Bardeesi AS; Yang Z; Cai W; Yang X; Gao G
Breast Cancer Res Treat; 2014 Nov; 148(1):61-72. PubMed ID: 25284724
[TBL] [Abstract][Full Text] [Related]
2. Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway.
Chen JM; Bai JY; Yang KX
IUBMB Life; 2018 Jun; 70(6):491-500. PubMed ID: 29637742
[TBL] [Abstract][Full Text] [Related]
3. Loss of pigment epithelium-derived factor: a novel mechanism for the development of endocrine resistance in breast cancer.
Jan R; Huang M; Lewis-Wambi J
Breast Cancer Res; 2012 Nov; 14(6):R146. PubMed ID: 23151593
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of RSK4 reverses doxorubicin resistance in human breast cancer cells via PI3K/AKT signalling pathway.
Mei Y; Liao X; Zhu L; Yang H
J Biochem; 2020 Jun; 167(6):603-611. PubMed ID: 31960922
[TBL] [Abstract][Full Text] [Related]
5. Magnoflorine improves sensitivity to doxorubicin (DOX) of breast cancer cells via inducing apoptosis and autophagy through AKT/mTOR and p38 signaling pathways.
Wei T; Xiaojun X; Peilong C
Biomed Pharmacother; 2020 Jan; 121():109139. PubMed ID: 31707337
[TBL] [Abstract][Full Text] [Related]
6. Synergy between PEDF and Doxorubicin in Breast Cancer Cells: Effects on Metastatic and Metabolic Pathways.
Abooshahab R; Al-Salami H; Dass CR
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474001
[TBL] [Abstract][Full Text] [Related]
7. The increasing role of pigment epithelium-derived factor in metastasis: from biological importance to a promising target.
Abooshahab R; Al-Salami H; Dass CR
Biochem Pharmacol; 2021 Nov; 193():114787. PubMed ID: 34571004
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor effects of pigment epithelium-derived factor (PEDF): implication for cancer therapy. A mini-review.
Belkacemi L; Zhang SX
J Exp Clin Cancer Res; 2016 Jan; 35():4. PubMed ID: 26746675
[TBL] [Abstract][Full Text] [Related]
9. Roles of pigment epithelium-derived factor in cardiomyocytes: implications for use as a cardioprotective therapeutic.
Jones IC; Dass CR
J Pharm Pharmacol; 2023 Jun; 75(6):746-757. PubMed ID: 37104852
[TBL] [Abstract][Full Text] [Related]
10. Regulation of MT1-MMP and MMP-2 by the serpin PEDF: a promising new target for metastatic cancer.
Alcantara MB; Dass CR
Cell Physiol Biochem; 2013; 31(4-5):487-94. PubMed ID: 23548673
[TBL] [Abstract][Full Text] [Related]
11. Cancer cell apoptotic pathways mediated by PEDF: prospects for therapy.
Broadhead ML; Dass CR; Choong PF
Trends Mol Med; 2009 Oct; 15(10):461-7. PubMed ID: 19783213
[TBL] [Abstract][Full Text] [Related]
12. The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential.
Becerra SP; Notario V
Nat Rev Cancer; 2013 Apr; 13(4):258-71. PubMed ID: 23486238
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
